JPMorgan Chase Reveals Market Update – This Stock Could Surge 116%

According to a note sent to clients by global investment strategist Madison Faller, JPMorgan Chase has a positive outlook despite a recent dip in the stock market. Financial technology firm TipRanks reports that Faller sees both opportunities and risks in the current economic climate, but remains optimistic overall. Faller also notes that volatility is a normal part of the market.

The stock market has experienced a 3.8% decrease in the last month, which has caused investors to panic and miss out on potential opportunities to buy low.

Faller suggests that instead of selling during dips, investors should take advantage of the fear and uncertainty in the market to make beneficial investments.

Similarly, in the crypto markets, JPMorgan Chase managing director Nikolaos Panigirtzoglou believes that a recent correction has resulted in limited downside, according to a report by Bloomberg.

According to Panigirtzoglou, the long-position liquidations are largely over, and “as a result, we see limited downside for crypto markets over the near term.”

Regarding individual stocks, according to TipRanks, Telephone & Data Systems (TDS) is a favorite of JPMorgan analyst Philip Cusick. TDS experienced a surge after the company announced its intention to sell its 83% stake in US Cellular.

Although the company’s earnings and sales during the second quarter fell short of expectations, Cusick believes that the restructuring could lead to a rally from $17.59 to $38 within a year, indicating a potential increase of 116%.

Moreover, JPMorgan analyst Eric Joseph predicts that HilleVax (HLVX), a vaccine development firm in the clinical stage, could see a significant increase in value as the company’s vaccines progress through trial stages.

Joseph has set a price target of $22, which is a 69% increase from its current price of $13.

Stay tuned for more news and make sure to keep your eyes peeled on the crypto market.